Search Results - "Quillien, V"

Comparative transcriptomics identifies genes underlying growth performance of the Pacific black-lipped pearl oyster Pinctada margaritifera by Dorant, Y, Quillien, V, Le Luyer, J, Ky, C L

“…In bivalves, the rate at which organisms grow is a major functional trait underlying many aspects of their commercial production. Growth is a highly polygenic…”
Get full text

Whole transcriptome sequencing and biomineralization gene architecture associated with cultured pearl quality traits in the pearl oyster, Pinctada margaritifera by Le Luyer, J, Auffret, P, Quillien, V, Leclerc, N, Reisser, C, Vidal-Dupiol, J, Ky, C-L

“…Cultured pearls are unique gems produced by living organisms, mainly molluscs of the Pinctada genus, through the biomineralization properties of pearl sac…”
Get full text

Substantial gene expression shifts during larval transitions in the pearl oyster Pinctada margaritifera by Destanque, T., Le Luyer, J., Quillien, V., Sham Koua, M., Auffrey, P., Ky, C.‐L.

“…Early development stages in marine bivalve are critical periods where larvae transition from pelagic free‐life to sessile mature individuals. The successive…”
Get full text

Bioactive extracellular compounds produced by the dinoflagellate Alexandrium minutum are highly detrimental for oysters by Castrec, J., Soudant, P., Payton, L., Tran, D., Miner, P., Lambert, C., Le Goïc, N., Huvet, A., Quillien, V., Boullot, F., Amzil, Z., Hégaret, H., Fabioux, C.

“…•Paralytic shellfish toxins (PSTs) and bioactive extracellular compounds (BECs) of Alexandrium minutum have contrasted effects upon Crassostrea gigas…”
Get full text

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study by Ursu, R., Thomas, L., Psimaras, D., Chinot, O., Le Rhun, E., Ricard, D., Charissoux, M., Cuzzubbo, S., Sejalon, F., Quillien, V., Hoang-Xuan, K., Ducray, F., Portal, J.-J., Tibi, A., Mandonnet, E., Levy-Piedbois, C., Vicaut, E., Carpentier, A.F.

“…Glioblastomas (GBMs) induce a peritumoural vasogenic oedema impairing functional status and quality of life. Steroids reduce brain tumour–related oedema but…”
Get full text

An external quality control to validate One Step Nucleic Acid (OSNA) amplification accuracy for detection of breast cancer lymph node metastasis by Godey, F, Gandon, G, Quillien, V

Get full text

Salinity influences disease-induced mortality of the oyster Crassostrea gigas and infectivity of the ostreid herpesvirus 1 (OsHV-1) by Fuhrmann, Marine, Petton, Bruno, Quillien, Virgile, Faury, Nicole, Morga, Benjamin, Pernet, Fabrice

“…Mortality of young Pacific oysters Crassostrea gigas associated with the ostreid herpesvirus 1 (OsHV-1) is occurring worldwide. Here, we examined for the first…”
Get full text

A concurrent ultra‐fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma by Beauchesne, P., Quillien, V., Faure, G., Bernier, V., Noel, G., Quetin, P., Gorlia, T., Carnin, C., Pedeux, R.

“…We report on a phase II clinical trial to determine the effect of a concurrent ultra‐fractionated radiotherapy and temozolomide treatment in inoperable…”
Get full text

Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma by Doucet, L., Cailleteau, A., Vaugier, L., Gourmelon, C., Bureau, M., Salaud, C., Roualdes, V., Samarut, E., Aumont, M., Zenatri, M., Loussouarn, D., Quillien, V., Bocquet, F., Payen-Gay, L., Joubert, D., Prieur, A., Robert, M., Frenel, J.-S.

“…Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG80, is a…”
Get full text

Thymidine Kinase as a Proliferative Marker: Clinical Relevance in 1,692 Primary Breast Cancer Patients by BROËT, P, ROMAIN, S, DAVER, A, RICOLLEAU, G, QUILLIEN, V, RALLET, A, ASSELAIN, B, MARTIN, P. M, SPYRATOS, F

“…To assess the prognostic value of thymidine kinase (TK), an enzyme involved in the DNA synthesis salvage pathway, relative to other prognostic factors in…”
Get full text

Association among growth, food consumption-related traits and amylase gene polymorphism in the Pacific oyster Crassostrea gigas by Huvet, A, Jeffroy, F, Fabioux, C, Daniel, J.Y, Quillien, V, Van Wormhoudt, A, Moal, J, Samain, J.F, Boudry, P, Pouvreau, S

“…To examine further a previously reported association between amylase gene polymorphism and growth in the Pacific oyster Crassostrea gigas, ecophysiological…”
Get full text

Protein S100 beta and Melanoma Inhibitory Activity (MIA): a prospective study of their clinical value for the early detection of metastasis in malignant melanoma by Loppin, M, Quillien, V, Adamski, H, Ollivier, I, Garlantézec, R, Chevrant-Breton, J

“…We examined whether serum values for proteins S100B and MIA could allow early and reliable screening of metastatic growth in melanoma. We carried out a…”
Get full text

Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study by BROËT, P, SPYRATOS, F, ROMAIN, S, QUILLIEN, V, DAVER, A, RICOLLEAU, G, RALLET, A, TOULAS, C, ASSELAIN, B

“…The purpose of this retrospective multicentre study was to assess the prognostic value of urokinase plasminogen activator (uPA) and p53 levels in a large…”
Get full text

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects by LESIMPLE, Thierry, MOISAN, Annick, LEFEUVRE-PLESSE, Claudia, CHEVRANT-BRETON, Jacqueline, TOUJAS, Louis, CARSIN, André, OLLIVIER, Isabelle, MOUSSEAU, Mireille, MEUNIER, Bernard, LEBERRE, Claudine, COLLET, Brigitte, QUILLIEN, Véronique, DRENOU, Bernard

“…Patients' autologous macrophages (AM) were used as antigen-presenting cells (APC) in a vaccination protocol against malignant melanoma. AM were administered by…”
Get full text

P29 - An external quality control to validate One Step Nucleic Acid (OSNA) amplification accuracy for detection of breast cancer lymph node metastasis by Godey, F., Gandon, G., Quillien, V.

Get full text

Integration of genomic alterations and expression profiling in Glioblastoma Multiforme by de Tayrac, M, Etcheverry, A, Aubry, M, Saïkali, S, Hamlat, A, Quillien, V, Mosser, J

Get full text

144P Development of a 6-color multiplex crystal digital PCR assay for the simultaneous detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients by Corné, J., Quillien, V., Godey, F., Le Du, F., Robert, L., Bourien, H., Brunot, A., Crouzet, L., Perrin, C., Lefeuvre-Plesse, C., Dieras, V.C., De La Motte Rouge, T.

Get full text

A new mutation in the BRCA1 gene (g.5196-5201del6, 5195-5202ins12), a 6 bp deletion replaced by the duplication of a 12 bp adjacent upstream intronic sequence by Hardouin, Agnès, Baumann, Jean-Jacques, Roussel, Gilbert, Quillien, Véronique, Dugast, Catherine, Berthet, Pascaline

Get full text

66P Impact of EPClin on adjuvant therapeutic decision-making and comparison of EPClin to PREDICT tool by Bourien, H., Quillien, V., Godey, F., Perrin, C., Le Du, F., Brunot, A., Crouzet, L., de La Motte Rouge, T., Dieras, V., Lefeuvre-Plesse, C.

Get full text

58P Detection of PIK3CA mutations in plasma ctDNA by Crystal Digital PCR for the selection of alpelisib treatment in routine clinical practice in advanced breast cancer patients by de La Motte Rouge, T., Le Du, F., Corne, J., Godey, F., Bourien, H., Brunot, A., Crouzet, L., Perrin, C., Lefeuvre-Plesse, C., Dieras, V.C., Quillien, V.

Get full text